VIB (Verening voor Inkoop en Bedrijfslogistiek - Association for Purchasing and Business Logistics) and PICS Belgium, a professional association for logistics services, awarded Janssen Supply Chain (JSC) the prestigious Supply Chain Award ‘Project of the year’ 2013. This prize is an acknowledgement of the important work that JSC carries out for improving our supply chain by means of the Global Planning Concept Design (GPCD) initiative.

“Our team members and I accept this prize with enormous pride on behalf of the many colleagues within JSC who contributed to GPCD”, said Stef Vermeiren, vice president Global Planning at JSC. “GPCD will have a considerable impact on our operations, while we make every effort to achieve the goal of this important initiative: turning JSC Planning into the benchmark, end-to-end (E2E) worldwide organisation that sustainably meets patients’ needs. This external recognition by VIB - PICS gives us the appropriate visibility among our colleagues in the logistics community in Belgium, and underlines both the importance of the goal of this project and the effectiveness of our approach for reaching that goal.”

Supply_Chain_Beerse_DL43.jpg
supply.jpg

The Global Planning Concept Design initiative won the “Project of the year” prize based on the following criteria:

  • Contribution to the total supply chain process
  • Degree of innovation
  • Added value for the company’s turnover
  • Extent to which the supply chain is able to respond flexibly to market changes and requirements
  • Handling changes
  • Measurability and evaluation of the results

The Janssen Supply Chain comprises 21 sites spread round the globe and in addition contracts delivery assignments to more than 150 external production partners. This kind of challenge only has a chance of succeeding with the aid of a harmonised planning strategy. That strategy has aroused much admiration and a handsome recognition as a result.

Durabilité
Économique

Janssen believes that strong corporate results, correct policies and focused activities pave the way towards economic sustainability. 

Janssen must constantly reinvent itself in order to cope with the structural and economic changes that affect its environment. This is why Janssen is committed to build partnerships within an open innovation model, and to the continuous alignment of its cost-competitiveness by only developing medicines with a high therapeutic added value. 

For Janssen this means specifically: being focused and a leader in research & development, and being efficient and progressive in terms of production with the aim of bringing new therapeutic solutions to patients quicker and at less expense, and implementing a growth strategy to ensure our continued investment in all these areas.